Volociximab
Jump to navigation
Jump to search
Volociximab | |
---|---|
Term | Volociximab |
Short definition | Volociximab - (pronounced) (voh-loh-SIK-sih-mab) monoclonal antibody being studied to treat some types of cancer. Monoclonal antibodies are made in the laboratory and can locate and attach to substances in the body, including cancer cells. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
Volociximab - (pronounced) (voh-loh-SIK-sih-mab) monoclonal antibody being studied to treat some types of cancer. Monoclonal antibodies are made in the laboratory and can locate and attach to substances in the body, including cancer cells. Volociximab attaches to a protein found on cells that line some tumor blood vessels. It's a type of angiogenesis inhibitor. Also called M200
External links
- Medical encyclopedia article on Volociximab
- Wikipedia's article - Volociximab
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski